Growth Metrics

AbCellera Biologics (ABCL) Exchange Rate Effect (2021 - 2026)

AbCellera Biologics filings provide 6 years of Exchange Rate Effect readings, the most recent being -$38000.0 for Q1 2026.

  • Quarterly Exchange Rate Effect fell 106.44% to -$38000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $469000.0 through Mar 2026, up 137.64% year-over-year, with the annual reading at $1.1 million for FY2025, 141.92% up from the prior year.
  • Exchange Rate Effect hit -$38000.0 in Q1 2026 for AbCellera Biologics, down from $290000.0 in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $1.1 million in Q4 2023 and bottomed at -$8.6 million in Q3 2022.
  • Average Exchange Rate Effect over 5 years is -$621647.1, with a median of -$43000.0 recorded in 2024.
  • The largest annual shift saw Exchange Rate Effect tumbled 3841.01% in 2022 before it soared 1869.77% in 2025.
  • AbCellera Biologics' Exchange Rate Effect stood at $364000.0 in 2022, then soared by 193.41% to $1.1 million in 2023, then tumbled by 302.25% to -$2.2 million in 2024, then surged by 113.43% to $290000.0 in 2025, then crashed by 113.1% to -$38000.0 in 2026.
  • Per Business Quant, the three most recent readings for ABCL's Exchange Rate Effect are -$38000.0 (Q1 2026), $290000.0 (Q4 2025), and -$544000.0 (Q3 2025).